K

Kora Saude Participacoes SA
BOVESPA:KRSA3

Watchlist Manager
Kora Saude Participacoes SA
BOVESPA:KRSA3
Watchlist
Price: 6.63 BRL 2% Market Closed
Market Cap: 509.5m BRL
Have any thoughts about
Kora Saude Participacoes SA?
Write Note

Intrinsic Value

The intrinsic value of one KRSA3 stock under the Base Case scenario is 26.81 BRL. Compared to the current market price of 6.63 BRL, Kora Saude Participacoes SA is Undervalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRSA3 Intrinsic Value
26.81 BRL
Undervaluation 75%
Intrinsic Value
Price
K
Base Case Scenario

Valuation Backtest
Kora Saude Participacoes SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KRSA3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KRSA3?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Kora Saude Participacoes SA

Provide an overview of the primary business activities
of Kora Saude Participacoes SA.

What unique competitive advantages
does Kora Saude Participacoes SA hold over its rivals?

What risks and challenges
does Kora Saude Participacoes SA face in the near future?

Summarize the latest earnings call
of Kora Saude Participacoes SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kora Saude Participacoes SA.

Provide P/S
for Kora Saude Participacoes SA.

Provide P/E
for Kora Saude Participacoes SA.

Provide P/OCF
for Kora Saude Participacoes SA.

Provide P/FCFE
for Kora Saude Participacoes SA.

Provide P/B
for Kora Saude Participacoes SA.

Provide EV/S
for Kora Saude Participacoes SA.

Provide EV/GP
for Kora Saude Participacoes SA.

Provide EV/EBITDA
for Kora Saude Participacoes SA.

Provide EV/EBIT
for Kora Saude Participacoes SA.

Provide EV/OCF
for Kora Saude Participacoes SA.

Provide EV/FCFF
for Kora Saude Participacoes SA.

Provide EV/IC
for Kora Saude Participacoes SA.

Show me price targets
for Kora Saude Participacoes SA made by professional analysts.

What are the Revenue projections
for Kora Saude Participacoes SA?

How accurate were the past Revenue estimates
for Kora Saude Participacoes SA?

What are the Net Income projections
for Kora Saude Participacoes SA?

How accurate were the past Net Income estimates
for Kora Saude Participacoes SA?

What are the EPS projections
for Kora Saude Participacoes SA?

How accurate were the past EPS estimates
for Kora Saude Participacoes SA?

What are the EBIT projections
for Kora Saude Participacoes SA?

How accurate were the past EBIT estimates
for Kora Saude Participacoes SA?

Compare the revenue forecasts
for Kora Saude Participacoes SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kora Saude Participacoes SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kora Saude Participacoes SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kora Saude Participacoes SA compared to its peers.

Compare the P/E ratios
of Kora Saude Participacoes SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Kora Saude Participacoes SA with its peers.

Analyze the financial leverage
of Kora Saude Participacoes SA compared to its main competitors.

Show all profitability ratios
for Kora Saude Participacoes SA.

Provide ROE
for Kora Saude Participacoes SA.

Provide ROA
for Kora Saude Participacoes SA.

Provide ROIC
for Kora Saude Participacoes SA.

Provide ROCE
for Kora Saude Participacoes SA.

Provide Gross Margin
for Kora Saude Participacoes SA.

Provide Operating Margin
for Kora Saude Participacoes SA.

Provide Net Margin
for Kora Saude Participacoes SA.

Provide FCF Margin
for Kora Saude Participacoes SA.

Show all solvency ratios
for Kora Saude Participacoes SA.

Provide D/E Ratio
for Kora Saude Participacoes SA.

Provide D/A Ratio
for Kora Saude Participacoes SA.

Provide Interest Coverage Ratio
for Kora Saude Participacoes SA.

Provide Altman Z-Score Ratio
for Kora Saude Participacoes SA.

Provide Quick Ratio
for Kora Saude Participacoes SA.

Provide Current Ratio
for Kora Saude Participacoes SA.

Provide Cash Ratio
for Kora Saude Participacoes SA.

What is the historical Revenue growth
over the last 5 years for Kora Saude Participacoes SA?

What is the historical Net Income growth
over the last 5 years for Kora Saude Participacoes SA?

What is the current Free Cash Flow
of Kora Saude Participacoes SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kora Saude Participacoes SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kora Saude Participacoes SA

Current Assets 1.4B
Cash & Short-Term Investments 228m
Receivables 951.4m
Other Current Assets 227.6m
Non-Current Assets 3.3B
Long-Term Investments 6.3m
PP&E 1.3B
Intangibles 1.9B
Other Non-Current Assets 169m
Current Liabilities 870.4m
Accounts Payable 435m
Other Current Liabilities 435.4m
Non-Current Liabilities 3B
Long-Term Debt 2.4B
Other Non-Current Liabilities 512.4m
Efficiency

Earnings Waterfall
Kora Saude Participacoes SA

Revenue
2.3B BRL
Cost of Revenue
-1.8B BRL
Gross Profit
461.6m BRL
Operating Expenses
-157.5m BRL
Operating Income
304.1m BRL
Other Expenses
-424.1m BRL
Net Income
-120m BRL

Free Cash Flow Analysis
Kora Saude Participacoes SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

During Q2 2024, Kora Saúde saw a modest 2% revenue growth to BRL 583 million, despite terminating partnerships with several insurance operators. Adjusted EBITDA stood at BRL 117 million, a drop from BRL 130 million in Q2 2023. Oncology services experienced robust growth, contributing BRL 46 million to net revenue. The company's occupancy rate remained strong at 79%. Significant efforts were made to enhance working capital and manage debt, including issuing debentures extending to 2029 and improving payment terms. Kora is optimistic about future growth, aligning strategies with insurance operators and planning new oncology centers.

What is Earnings Call?
Fundamental Scores

KRSA3 Profitability Score
Profitability Due Diligence

Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Positive Revenue Growth Forecast
42/100
Profitability
Score

Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

KRSA3 Solvency Score
Solvency Due Diligence

Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
25/100
Solvency
Score

Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRSA3 Price Targets Summary
Kora Saude Participacoes SA

Wall Street analysts forecast KRSA3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRSA3 is 36.9 BRL with a low forecast of 5.05 BRL and a high forecast of 126 BRL.

Lowest
Price Target
5.05 BRL
24% Downside
Average
Price Target
36.9 BRL
457% Upside
Highest
Price Target
126 BRL
1 800% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KRSA3?

Click here to dive deeper.

Dividends

Kora Saude Participacoes SA
does not pay dividends
Shareholder Yield

Current shareholder yield for KRSA3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kora Saude Participacoes SA

Country

Brazil

Industry

Health Care

Market Cap

509.5m BRL

Dividend Yield

0%

Description

Kora Saude Participaçoes SA engages in managing health care facilities. The company is headquartered in Vitoria, Espirito Santo. The company went IPO on 2021-08-13. With a presence in the management of hospital beds in five states (Espirito Santo, Mato Grosso, Tocantins, Goiania and Ceara) and in the satellite cities of the Federal District, the Company also operates a park offering diagnostic and therapeutic support services, including oncology, clinical, radiology, hemodynamics and others. The firm has hospital expansion (brownfields) and hospital construction (greenfields) projects. The vast majority of professionals who provide services in the Company's hospitals are independent.

Contact

ESPIRITO SANTO
Vitoria
Av Desembargador Santos Neves 207, Santa Lucia
+552733463734
www.korasaude.com.br

IPO

2021-08-13

Employees

4 500

Officers

CEO & Director
Mr. Antonio Alves Benjamim Neto
CFO & Investor Relations Officer
Mr. Elias Leal Lima
Chief Operating Officer
Mr. Marcio Augusto Pitta Machado
Chief Accounting Officer
Mr. Diogo Sandoval Fernandes
Chief Technology Officer
Mr. Alex Fernandes Amorim Julian
Director of People & Management and HR Officer
Ms. Lorena Morelato
Show More
Chief Commercial Officer
Michel Castro Santana
Chief Integration & Operational Excellence Officer
Mr. Daniel Pangracio Ahouagi Cunha
Show Less

See Also

Discover More
What is the Intrinsic Value of one KRSA3 stock?

The intrinsic value of one KRSA3 stock under the Base Case scenario is 26.81 BRL.

Is KRSA3 stock undervalued or overvalued?

Compared to the current market price of 6.63 BRL, Kora Saude Participacoes SA is Undervalued by 75%.

Back to Top